Cryoport (CYRX) Competitors $6.14 -0.60 (-8.90%) Closing price 04:00 PM EasternExtended Trading$6.14 0.00 (0.00%) As of 07:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CYRX vs. VERA, DYN, GPCR, ANIP, SPRY, CALT, ETNB, OCUL, AMPH, and BGMShould you be buying Cryoport stock or one of its competitors? The main competitors of Cryoport include Vera Therapeutics (VERA), Dyne Therapeutics (DYN), Structure Therapeutics (GPCR), ANI Pharmaceuticals (ANIP), ARS Pharmaceuticals (SPRY), Calliditas Therapeutics AB (publ) (CALT), 89bio (ETNB), Ocular Therapeutix (OCUL), Amphastar Pharmaceuticals (AMPH), and Qilian International Holding Group (BGM). These companies are all part of the "pharmaceutical products" industry. Cryoport vs. Vera Therapeutics Dyne Therapeutics Structure Therapeutics ANI Pharmaceuticals ARS Pharmaceuticals Calliditas Therapeutics AB (publ) 89bio Ocular Therapeutix Amphastar Pharmaceuticals Qilian International Holding Group Cryoport (NASDAQ:CYRX) and Vera Therapeutics (NASDAQ:VERA) are both small-cap transportation companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, community ranking, earnings, media sentiment, analyst recommendations and profitability. Does the media favor CYRX or VERA? In the previous week, Vera Therapeutics had 10 more articles in the media than Cryoport. MarketBeat recorded 15 mentions for Vera Therapeutics and 5 mentions for Cryoport. Cryoport's average media sentiment score of 1.29 beat Vera Therapeutics' score of 1.17 indicating that Cryoport is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cryoport 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Vera Therapeutics 12 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is CYRX or VERA more profitable? Vera Therapeutics has a net margin of 0.00% compared to Cryoport's net margin of -70.08%. Cryoport's return on equity of -13.35% beat Vera Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Cryoport-70.08% -13.35% -6.43% Vera Therapeutics N/A -50.13%-39.50% Do institutionals & insiders have more ownership in CYRX or VERA? 92.9% of Cryoport shares are owned by institutional investors. Comparatively, 99.2% of Vera Therapeutics shares are owned by institutional investors. 10.0% of Cryoport shares are owned by insiders. Comparatively, 16.3% of Vera Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Do analysts prefer CYRX or VERA? Cryoport currently has a consensus target price of $11.00, suggesting a potential upside of 80.24%. Vera Therapeutics has a consensus target price of $63.33, suggesting a potential upside of 210.37%. Given Vera Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Vera Therapeutics is more favorable than Cryoport.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cryoport 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.71Vera Therapeutics 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 3.10 Which has better earnings & valuation, CYRX or VERA? Vera Therapeutics has lower revenue, but higher earnings than Cryoport. Vera Therapeutics is trading at a lower price-to-earnings ratio than Cryoport, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCryoport$232.13M1.32-$99.59M-$2.34-2.61Vera TherapeuticsN/AN/A-$95.99M-$3.00-6.80 Does the MarketBeat Community prefer CYRX or VERA? Cryoport received 209 more outperform votes than Vera Therapeutics when rated by MarketBeat users. However, 66.15% of users gave Vera Therapeutics an outperform vote while only 65.80% of users gave Cryoport an outperform vote. CompanyUnderperformOutperformCryoportOutperform Votes25265.80% Underperform Votes13134.20% Vera TherapeuticsOutperform Votes4366.15% Underperform Votes2233.85% Which has more volatility & risk, CYRX or VERA? Cryoport has a beta of 1.92, suggesting that its share price is 92% more volatile than the S&P 500. Comparatively, Vera Therapeutics has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500. SummaryVera Therapeutics beats Cryoport on 10 of the 18 factors compared between the two stocks. Get Cryoport News Delivered to You Automatically Sign up to receive the latest news and ratings for CYRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CYRX vs. The Competition Export to ExcelMetricCryoportPharmaceutical IndustryTransportation SectorNASDAQ ExchangeMarket Cap$306.09M$6.55B$285.11B$8.53BDividend YieldN/A2.66%3.78%4.11%P/E Ratio-1.819.1613.9019.97Price / Sales1.32258.53270.66122.22Price / Cash16.9565.8511.5434.62Price / Book0.656.541.924.59Net Income-$99.59M$143.98M$512.32M$248.18M7 Day Performance-5.67%4.65%-1.57%2.15%1 Month Performance10.56%9.18%11.64%16.14%1 Year Performance-48.67%-1.33%-10.07%8.06% Cryoport Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CYRXCryoport3.0174 of 5 stars$6.14-8.9%$11.00+79.2%-43.2%$307.84M$232.13M-1.821,020News CoveragePositive NewsVERAVera Therapeutics3.3651 of 5 stars$22.49+3.6%$63.33+181.6%-48.2%$1.43BN/A-8.6240Positive NewsDYNDyne Therapeutics3.7405 of 5 stars$12.56+10.1%$46.85+273.0%-65.1%$1.43BN/A-3.53100Positive NewsGap DownHigh Trading VolumeGPCRStructure Therapeutics2.1255 of 5 stars$24.62-3.7%$78.00+216.8%-31.1%$1.41BN/A-33.27136Gap UpANIPANI Pharmaceuticals4.8288 of 5 stars$62.30-6.0%$80.13+28.6%-1.8%$1.36B$614.38M-113.27600Positive NewsHigh Trading VolumeSPRYARS Pharmaceuticals2.4345 of 5 stars$13.29-1.1%$31.00+133.3%+55.9%$1.31B$89.15M-26.0690Trending NewsEarnings ReportAnalyst RevisionCALTCalliditas Therapeutics AB (publ)N/A$40.00flat$39.25-1.9%N/A$1.19B$1.60B-21.62180ETNB89bio2.8936 of 5 stars$8.11+5.3%$27.25+236.0%+1.0%$1.18BN/A-2.7940Positive NewsOCULOcular Therapeutix4.2502 of 5 stars$7.39+4.7%$16.25+119.9%+20.8%$1.18B$59.65M-5.60230Gap UpAMPHAmphastar Pharmaceuticals4.2514 of 5 stars$24.34+1.0%$32.33+32.8%-41.8%$1.16B$731.97M8.111,620BGMQilian International Holding GroupN/A$11.42+3.5%N/AN/A$1.11B$25.10M0.00298Positive NewsGap Up Related Companies and Tools Related Companies Vera Therapeutics Competitors Dyne Therapeutics Competitors Structure Therapeutics Competitors ANI Pharmaceuticals Competitors ARS Pharmaceuticals Competitors Calliditas Therapeutics AB (publ) Competitors 89bio Competitors Ocular Therapeutix Competitors Amphastar Pharmaceuticals Competitors Qilian International Holding Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CYRX) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cryoport, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cryoport With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CYRX Stock Free CYRX Stock Alerts